Krejci, Marta <br/><br/>
Salvage treatment with upfront melphalan 100 mg/m(2) and consolidation with novel drugs for fulminant progression of multiple myeloma.  [electronic resource] 

 -  Annals of hematology  May 2010 
 - 483-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0584 
<br/><br/><label>Standard No.: </label>10.1007/s00277-009-0862-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Disease Progression<br/>Drug Administration Schedule<br/>Follow-Up Studies<br/>Humans<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Retrospective Studies<br/>Salvage Therapy--methods<br/>Treatment Outcome